Anthrax
Complement depletion renders mice sensitive to Bacillus anthracis
Published in Medical Letter on the CDC and FDA, August 14th, 2005
According to recent research published in the journal Infection and Immunity, "Concerns regarding safety and control of virulent Bacillus anthracis have created substantial hurdles to the study of anthrax. The Sterne strain is considered relatively safe to study, but this acapsular strain has a defect in normal mice and is often studied in A/J mice. A/J mice are highly susceptible to the Sterne strain, due to a defect in the Hc locus, which encodes complement factor 5 (C5)."
"Here we show that normally resistant C57BL/6 mice become highly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- HIV/AIDS Vaccine
Impact of HIV genetic diversity on vaccine development reviewed - Lyssaviruses
Rabies biologics are effective against some lyssaviruses from Eurasia - Measles Virus
Amino acid variations affecting measles virus replication identified - Outbreaks
Seed source identified for E. coli outbreaks linked to sprouts - Hemophilus ducreyi
H. ducreyi dsrA mutant killed by normal human serum initiated by IgM binding - Adverse Drug Reactions
Importance of reporting suspected adverse drug reactions emphasized - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
